GSA Capital Partners LLP Purchases 377,721 Shares of ASP Isotopes Inc. (NASDAQ:ASPI)

GSA Capital Partners LLP lifted its stake in shares of ASP Isotopes Inc. (NASDAQ:ASPI - Free Report) by 96.0% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 770,989 shares of the company's stock after buying an additional 377,721 shares during the quarter. GSA Capital Partners LLP owned approximately 1.13% of ASP Isotopes worth $2,143,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Fielder Capital Group LLC bought a new position in shares of ASP Isotopes in the 2nd quarter worth about $55,000. Rhumbline Advisers acquired a new position in shares of ASP Isotopes during the second quarter worth approximately $116,000. Virtu Financial LLC grew its holdings in ASP Isotopes by 477.0% in the 1st quarter. Virtu Financial LLC now owns 83,677 shares of the company's stock worth $346,000 after buying an additional 69,176 shares in the last quarter. HTLF Bank increased its position in ASP Isotopes by 197.0% in the 2nd quarter. HTLF Bank now owns 105,538 shares of the company's stock valued at $323,000 after acquiring an additional 70,000 shares during the period. Finally, Bank of New York Mellon Corp bought a new stake in ASP Isotopes during the 2nd quarter valued at $381,000. Institutional investors own 16.80% of the company's stock.

ASP Isotopes Price Performance

ASP Isotopes stock traded up $0.06 during mid-day trading on Tuesday, hitting $8.33. The company's stock had a trading volume of 3,534,359 shares, compared to its average volume of 1,444,361. The stock has a market capitalization of $592.79 million, a P/E ratio of -14.06 and a beta of 3.88. The company has a quick ratio of 4.00, a current ratio of 4.00 and a debt-to-equity ratio of 2.06. The stock's fifty day moving average price is $4.01 and its two-hundred day moving average price is $3.59. ASP Isotopes Inc. has a twelve month low of $1.45 and a twelve month high of $9.33.

ASP Isotopes (NASDAQ:ASPI - Get Free Report) last announced its earnings results on Monday, August 19th. The company reported ($0.24) earnings per share (EPS) for the quarter. The business had revenue of $1.02 million for the quarter. Research analysts forecast that ASP Isotopes Inc. will post -0.24 earnings per share for the current year.

Analysts Set New Price Targets

ASPI has been the subject of several research analyst reports. Canaccord Genuity Group started coverage on shares of ASP Isotopes in a report on Friday, October 4th. They issued a "buy" rating and a $4.50 price objective for the company. Canaccord Genuity Group restated a "buy" rating and issued a $4.50 target price on shares of ASP Isotopes in a research report on Friday, October 18th. Finally, HC Wainwright dropped their price objective on ASP Isotopes from $5.50 to $4.50 and set a "buy" rating on the stock in a research note on Wednesday, August 7th.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.